Latest Resmed News & Updates

See the latest news and media coverage for Resmed. We track all announcements, press releases, and industry mentions in real time, all in one place.

Resmed

Connected solutions for sleep apnoea and respiratory care

resmed.co.uk

Headquarters: San Diego, United States
Company type: Public company
Number of employees: 9,000–10,000

Last updated Today

Latest news about Resmed

In short: Resmed achieved 11% revenue growth in Q3 2026, completed a strategic acquisition, and underwent a CFO transition amidst fluctuating stock prices.

Company announcements

Yesterday Resmed

Resmed named #31 on WSJ Best Companies list

It ranked #2 in Health Care category, recognized for advancing sleep and breathing care.

Yesterday Resmed

Resmed joins FORTIFY to enable trusted health data sharing

The consortium will develop legal, governance, and technical tools for secondary health data use while protecting innovation.

June 1 Resmed

Resmed completes acquisition of Noctrix Health

The deal adds Nidra TOMAC therapy for Restless Legs Syndrome, expanding Resmed's clinical sleep health portfolio.

April 30 Resmed

Resmed reports 11% revenue growth in Q3 fiscal 2026

Revenue reached $1.4 billion, gross margin improved 290 bps, and EPS rose to $2.74.

Media coverage

June 9 Investing.com

ResMed chairman & CEO Michael Farrell sells $968k in stock By Investing.com

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may...

June 5 Kalkine

ResMed (ASX:RMD) Gains as Investors Rotate Into Defensive Health Care Winners

ResMed (ASX:RMD) gained 4.15% to $27.60 at the time of writing on 5 June 2026, as investors rotated into defensive health care names on a...

June 3 The Globe and Mail

Resmed Inc. Announces Results for the Third Quarter of Fiscal Year 2026

SAN DIEGO, April 30, 2026 (GLOBE NEWSWIRE) -- Resmed Inc. (NYSE: RMD, ASX: RMD) today announced results for its quarter ended March 31, 2026.

June 2 The Star

Resmed Completes Acquisition of Noctrix Health, Expanding Clinical Sleep Health Portfolio

SAN DIEGO, June 01, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered...

Never miss news about Resmed

Track Resmed and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.